TheraBiogen, Inc. Announces Food Lion LLC Will Sell Its TheraMax(R) Cold & Flu Relief Products in All of Their Stores Nationwide

NEW YORK, NY--(Marketwire - June 03, 2011) - TheraBiogen, Inc. (OTCBB: TRAB) is pleased to announce it is in agreement with Food Lion LLC Company for distribution nationally in all their locations for the 2011-2012 cold and flu season.

TheraBiogen, Inc. adds to their list of retailers that sell its TheraMax® products. Food Lion LLC Company has an agreement with TheraBiogen to carry and sell both TheraMax® Cold & Flu Relief and TheraMax® Allergy Relief in approximately 1150 of its supermarket stores. Delhaize America operates supermarkets under various names such as Food Lion, Harveys Supermarket, Bloom, Bottom Dollar Food, and Reid’s. The stores are located in 11 Mid-Atlantic and South Atlantic states as well as Tennessee, Kentucky and West Virginia. The TheraMax® products will be available in the stores by the third quarter of the year. “This is another big step for TheraBiogen as it continuously expands its TheraMax® product availability to consumers,” said Kelly Hickel CEO of TheraBiogen, Inc.

TheraMax™ is available for purchase in thousands of locations from Rite-Aid, Walgreens Miami South District, Hannaford Supermarkets, Discount Drug Marts and Big Y Supermarkets. For more information on TheraMax™ visit our website www.theramaxrelief.com or our Facebook page at www.facebook.com/theramaxnasalspray.

About TheraBiogen
TheraBiogen, Inc. is the manufacturer and distributor of homeopathic nasal sprays for aiding in the relief of allergies and cold and flu symptoms. The products are made from natural, homeopathic ingredients and contain no zinc, which has been identified as potentially causing nasal problems in other similar products on the market. For further information please visit www.theramaxrelief.com.

Safe Harbor Statement
This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21 E of the Securities Exchange Act of 1934, as amended. Investors are cautioned that these forward-looking statements involve uncertainties and risk that could cause actual performance and results of operations to differ materially from those anticipated. These risks are set forth in the Company’s most recently filed form 10-K and Form 10-Q reports. TheraBiogen, Inc. assumes no obligation to update the statements contained in this release except as required by applicable securities laws disclosure rules.